GC
VIVS

Guggenheim Capital’s VivoSim Labs VIVS Stock Holding History

Guggenheim Capital’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,580
Closed -$2.75M – 3086
2014
Q4 		$2.75M Buy
1,580
+140
+10% +$215K 0.01% 1492
2014
Q3 		$2.2M Buy
1,440
+72
+5% +$131K 0.01% 1695
2014
Q2 		$2.74M Buy
1,368
+20
+1% +$33.5K 0.01% 1553
2014
Q1 		$2.47M Buy
1,348
+143
+12% +$332K 0.01% 1610
2013
Q4 		$3.2M Sell
1,205
-141
-10% -$277K 0.01% 1363
2013
Q3 		$1.86M Buy
+1,346
New +$1.88M 0.01% 1664

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Guggenheim Capital's VIVS Position: Q1 2015 in Review

Guggenheim Capital sold out of VivoSim Labs (VIVS) in Q1 2015, closing a stake of 1,580 shares — an estimated $2.75M sold.

Guggenheim Capital first reported a position in VIVS in Q3 2013 and held it in 6 quarters. The position peaked at $3.2M in Q4 2013. 104 funds tracked by Wall St. Rank hold VIVS as of Q1 2015.

  • Guggenheim Capital reported no remaining VivoSim Labs position as of Q1 2015 after selling out during the quarter.
  • Guggenheim Capital sold 1,580 VivoSim Labs shares in Q1 2015, an estimated $2.75M.
  • Guggenheim Capital first reported a position in VivoSim Labs in Q3 2013 and held it in 6 quarters.
  • Guggenheim Capital's VivoSim Labs position peaked at $3.2M in Q4 2013.
  • 104 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2015.

Based on Guggenheim Capital's 13F filing for Q1 2015, filed 15 May 2015.